These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1664168)

  • 1. [Characterization of 9 slowly dissociated opioid ligands azabicyclononances compounds to mu, delta, and kappa receptors].
    Fan LQ; Jin WQ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):245-9. PubMed ID: 1664168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-7521--a new irreversible opioid ligand.
    Jin WQ; Fan LQ; Chen XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):205-10. PubMed ID: 2558497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent and long-lasting ligand, azabicyclononane (P-7521).
    Chi ZQ; Jin WQ
    Prog Clin Biol Res; 1990; 328():1-4. PubMed ID: 2154758
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
    Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic activity and opioid receptor selectivity of stereoisomers of ohmefentanyl isothiocyanate.
    Chen BY; Jin WQ; Chen XJ; Zhu YC; Chi ZQ
    Eur J Pharmacol; 2001 Jul; 424(3):195-8. PubMed ID: 11672562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
    Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F
    Peptides; 1982; 3(5):793-7. PubMed ID: 6294635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P-8502--a new mu selective opioid receptor ligand].
    Ge BL; Zhang HP; Xu YP; Zheng WJ
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):13-6. PubMed ID: 2554665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13).
    Lemaire S; Dumont M; Jolicoeur F; Belleau B
    Can J Physiol Pharmacol; 1986 Jun; 64(6):707-11. PubMed ID: 2875779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic activity and selectivity for opioid receptors of enantiomers of ohmefentanyl.
    Jin WQ; Wang ZX; Chen J; Chen XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):421-4. PubMed ID: 9863164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivity.
    Bertha CM; Ellis M; Flippen-Anderson JL; Porreca F; Rothman RB; Davis P; Xu H; Becketts K; Rice KC
    J Med Chem; 1996 May; 39(10):2081-6. PubMed ID: 8642567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.